Company record
Nextcea, Inc. develops drug‑development solutions aimed at enhancing efficacy while reducing toxicity throughout every stage of the pipeline. Its portfolio comprises stage‑specific pharmaceutical candidates, cross‑species ADME assessments, biomarker analysis services, and bioinformatics platforms focused on drug metabolism.
This directory record does not yet have a linked material-flow brief.